BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24323815)

  • 21. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer.
    Pimiento JM; Davis-Yadley AH; Kim RD; Chen DT; Eikman EA; Berman CG; Malafa MP
    Clin Nucl Med; 2016 Mar; 41(3):177-81. PubMed ID: 26673243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
    Parikh U; Marcus C; Sarangi R; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):327-43. PubMed ID: 26099670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.
    Dong A; Wang Y; Dong H; Zhang J; Cheng C; Zuo C
    Clin Nucl Med; 2013 Mar; 38(3):e118-24. PubMed ID: 23354028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.
    Wang XY; Yang F; Jin C; Guan YH; Zhang HW; Fu DL
    Hepatogastroenterology; 2014 Oct; 61(135):2102-9. PubMed ID: 25722999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome.
    Kulkarni M; Purandare N; Zade A; Agrawal A; Shah S; Rangarajan V
    Clin Nucl Med; 2013 Jul; 38(7):e302-3. PubMed ID: 23486326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic and thyroid metastases detected with 18F-FDG PET/CT in patient with colorectal cancer.
    Castillo Morales V; García Alonso P; Balsa Bretón MA; Ortega Valle A; Penín González J; Pey Illera C
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):335-7. PubMed ID: 22998928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.
    Luo Y; Hu W; Wu H; Xue H; Huo L; Li F; Zhao Y; Dai M
    Int J Clin Exp Pathol; 2014; 7(10):7278-85. PubMed ID: 25400826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
    Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.
    Kim MJ; Lee KH; Lee KT; Lee JK; Ku BH; Oh CR; Heo JS; Choi SH; Choi DW
    Pancreas; 2012 Aug; 41(6):897-903. PubMed ID: 22699202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. F-18 FDG PET/CT imaging of multifocal extramedullary pancreatic myeloma.
    Nguyen BD; Ram PC
    Clin Nucl Med; 2010 Mar; 35(3):198-201. PubMed ID: 20173459
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis.
    Rijkers AP; Valkema R; Duivenvoorden HJ; van Eijck CH
    Eur J Surg Oncol; 2014 Jul; 40(7):794-804. PubMed ID: 24755095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple Pathologies Seen on a Single Contrast-Enhanced 18F-FDG PET/CT: Reiteration of Lessons Previously Learned.
    Sharma P; Marangmei C
    Clin Nucl Med; 2015 Sep; 40(9):750-1. PubMed ID: 25706797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic embryonal rhabdomyosarcoma to the pancreas presenting as acute pancreatitis detected by FDG PET/CT.
    Yang J; Codreanu I; Servaes S; Zhuang H
    Clin Nucl Med; 2012 Jul; 37(7):694-6. PubMed ID: 22691517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
    Ozkan E; Soydal C; Araz M; Aras G
    Nucl Med Commun; 2012 Sep; 33(9):990-4. PubMed ID: 22842225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET/CT of cancer patients: part 1, pancreatic neoplasms.
    Dibble EH; Karantanis D; Mercier G; Peller PJ; Kachnic LA; Subramaniam RM
    AJR Am J Roentgenol; 2012 Nov; 199(5):952-67. PubMed ID: 23096166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET/MR in an Atypical Pediatric Solid Pseudopapillary Pancreatic Tumor.
    Cavaliere A; Giraudo C; Zuliani M; Cecchin D; Quaia E
    Clin Nucl Med; 2019 Sep; 44(9):e522-e523. PubMed ID: 31274565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.